Low-Gluten Diet Alters the Human Microbiome

A study of Danish adults reveals moderate changes in the abundance of multiple gut bacteria species, but the results might not be due to reduced gluten per se.

Written byCatherine Offord
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: WIKIMEDIA, NATIONAL CANCER INSTITUTE

Going on a low-gluten diet moderately alters the composition of bacterial species in the human gut, according to the results of a randomized controlled trial published today (November 13) in Nature Communications. The results suggest that some of the positive effects associated with a low-gluten diet, such as reduced bloating after meals, may be the result of diet-induced changes in the intestinal microbiome.

To study the effect of a low-gluten diet, researchers in Denmark recruited 60 middle-aged, healthy adults. Participants followed a specialized diet for eight weeks—either low gluten (2 g per day) or high gluten (12 g per day). Then, after a six week break, they switched.

An analysis of the participants’ microbiome composition revealed that, of hundreds of bacterial species identified across the cohort, 14 consistently experienced changes in relative abundance in response to a low-gluten diet. For example, four species of Bifidobacterium, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies